Aurinia

Shares of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity, ticked higher by more than 3 percent early Friday morning after the company presented results from an ongoing study. Aurinia presented remission...